Prostate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathology

AbstractObjectivesTo evaluate the diagnostic performance of preoperative multiparametric MRI with extracapsular extension (ECE) risk-scoring in the assessment of prostate cancer tumour stage (T-stage) and prediction of ECE at final pathology.Materials and MethodsEighty-seven patients with clinically localised prostate cancer scheduled for radical prostatectomy were prospectively enrolled. Multiparametric MRI was performed prior to prostatectomy, and evaluated according to the ESUR MR prostate guidelines by two different readers. An MRI clinical T-stage (cTMRI), an ECE risk score, and suspicion of ECE based on tumour characteristics and personal opinion were assigned. Histopathological prostatectomy results were standard reference.ResultsHistopathology and cTMRI showed a spearman rho correlation of 0.658 (p < 0.001) and a weighted kappa = 0.585 [CI 0.44;0.73](reader A). ECE was present in 31/87 (36 %) patients. ECE risk-scoring showed an AUC of 0.65–0.86 on ROC-curve for both readers, with sensitivity and specificity of 81 % and 78 % at best cutoff level (reader A), respectively. When tumour characteristics were influenced by personal opinion, the sensitivity and specificity for prediction of ECE changed to 61 %–74 % and 77 %-88 % for the readers, respectively.ConclusionsMultiparametric MRI with ECE risk-scoring is an accurate diagnostic technique in determining prostate cancer clinical tumour stage and ECE at final pathology.Key Points• Multiparametric MRI is an accurate diagnostic technique for preoperative prostate cancer staging • ECE risk scoring predicts extracapsular tumour extension at final pathology • ECE risk scoring shows an AUC of 0.86 on the ROC-curve • ECE risk scoring shows a moderate inter-reader agreement (K = 0.45) • Multiparametric MRI provides essential knowledge for optimal clinical management

[1]  E. Bergstralh,et al.  Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate‐specific antigen testing: 15‐year outcome , 2005, BJU international.

[2]  P. Grenier,et al.  Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective study. , 2013, Urologic oncology.

[3]  Jelle O. Barentsz,et al.  Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal–pelvic phased-array coils , 2007, European Radiology.

[4]  M. Soulié,et al.  What is the Role of Surgery for Locally Advanced Disease , 2008 .

[5]  M Bolla,et al.  EAU guidelines on prostate cancer. , 2001, European urology.

[6]  Jelle O. Barentsz,et al.  Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis , 2002, European Radiology.

[7]  Baris Turkbey,et al.  Comparison of endorectal coil and nonendorectal coil T2W and diffusion‐weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole‐mount histopathology , 2014, Journal of magnetic resonance imaging : JMRI.

[8]  H. Schlemmer,et al.  [PI-RADS classification: structured reporting for MRI of the prostate]. , 2013, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[9]  A. Levy,et al.  Prostate Cancer: Local Staging at 3-T Endorectal MR Imaging—Early Experience , 2006 .

[10]  M. Kattan,et al.  Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. , 2006, Radiology.

[11]  Henrik S. Thomsen,et al.  Early experience with multiparametric magnetic resonance imaging-targeted biopsies under visual transrectal ultrasound guidance in patients suspicious for prostate cancer undergoing repeated biopsy , 2015, Scandinavian journal of urology.

[12]  Thomas Hambrock,et al.  Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance. , 2007, Radiology.

[13]  A. D'Amico,et al.  Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer. , 2013, International journal of radiation oncology, biology, physics.

[14]  M. Kattan,et al.  Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer , 2012, BJU international.

[15]  J. Babb,et al.  Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. , 2013, Radiology.

[16]  Hugh J. Lavery,et al.  Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer , 2011, BJU international.

[17]  B. K. Park,et al.  Value of diffusion-weighted imaging at 3 T for prediction of extracapsular extension in patients with prostate cancer: a preliminary study. , 2014, AJR. American journal of roentgenology.

[18]  Leslie H. Sobin,et al.  Comprar TNM Classification of Malignant Tumours, 7th Edition | C. Wittekind | 9781444332414 | Wiley , 2009 .

[19]  Robert E Lenkinski,et al.  Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. , 2007, Radiology.

[20]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[21]  J. Mazeron,et al.  TNM classification of malignant tumours (5 e dition) , 1998 .

[22]  S. Boorjian,et al.  20‐year survival after radical prostatectomy as initial treatment for cT3 prostate cancer , 2012, BJU international.

[23]  T. Scheenen,et al.  Prostate cancer: local staging at 3-T endorectal MR imaging--early experience. , 2006, Radiology.

[24]  Kingshuk Roy Choudhury,et al.  Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis , 2014, Abdominal Imaging.

[25]  M. Kattan,et al.  Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. , 2005, The Journal of urology.

[26]  P. Mozer,et al.  Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. , 2012, European urology.

[27]  U. Capitanio,et al.  Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease. , 2012, The Journal of urology.

[28]  D. Lubeck,et al.  Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. , 2001, The Journal of urology.

[29]  J Alfred Witjes,et al.  Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. , 2005, Radiology.

[30]  M. Roethke,et al.  Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla , 2014, European Radiology.

[31]  Michael W Kattan,et al.  Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. , 2004, Radiology.

[32]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[33]  J. Armstrong,et al.  Early salvage hormonal therapy for biochemical failure improved survival in prostate cancer patients after neoadjuvant hormonal therapy plus radiation therapy--a secondary analysis of irish clinical oncology research group 97-01. , 2013, International journal of radiation oncology, biology, physics.

[34]  Valeria Panebianco,et al.  Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. , 2011, European urology.

[35]  M. Röthke,et al.  PI-RADS-Klassifikation: Strukturiertes Befundungsschema für die MRT der Prostata , 2013, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[36]  J. Babb,et al.  Prostate cancer: Utility of diffusion‐weighted imaging as a marker of side‐specific risk of extracapsular extension , 2013, Journal of magnetic resonance imaging : JMRI.

[37]  A. Heidenreich.  Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. , 2011, European urology.

[38]  T. H. van der Kwast,et al.  EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. , 2014, European urology.

[39]  T. Roskams,et al.  Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience. , 2007, European urology.

[40]  Boris Bodelle,et al.  MRI of the prostate: interobserver agreement compared with histopathologic outcome after radical prostatectomy. , 2012, European journal of radiology.